Securities code: 300199 securities abbreviation: Hybio Pharmaceutical Co.Ltd(300199) Announcement No.: 2022-017 Hybio Pharmaceutical Co.Ltd(300199)
Announcement on the reduction of more than 1% by shareholders holding more than 5%
Peng Tong, the shareholder, guarantees that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Hybio Pharmaceutical Co.Ltd(300199) (hereinafter referred to as the "company" or " Hybio Pharmaceutical Co.Ltd(300199) ") received the notification letter on share reduction (hereinafter referred to as the "notification letter") from Peng Tong, a natural person shareholder holding more than 5% of the shares, on January 25, 2022. Peng Tong reduced 18.33 million shares through block trading on January 24, 2022, accounting for 1.9991% of the total share capital of the company. The specific situation is hereby announced as follows: 1 Basic information
Information disclosure obligor Peng Tong
Address: zijingyuan, No. 3, Jingtian Road, Futian District, Shenzhen, Guangdong
Change time of Equity: January 24, 2022
Stock abbreviation Hybio Pharmaceutical Co.Ltd(300199) stock code 300199
Change type
(more can be added □ less √ concerted action □ none √
(optional)
Whether it is the largest shareholder or actual controller yes □ no √
2. Changes in equity this time
Type of shares number of shares reduced (10000 shares) reduction proportion (%)
A shares 1833 1.9991%
Total 1833 1.9991%
Centralized trading through stock exchanges □ transfer by agreement □ block trading through stock exchanges √ indirect transfer □ method of this equity change (administrative transfer or change of multi-national shares □ execution of court ruling □ selection) Acquisition of new shares issued by a listed company □ inheritance □ gift □ transfer of voting rights □ others □ (please specify)
Self owned funds □ bank loans □
The capital source of this share increase is loans from other financial institutions □ shareholder investment □
(multiple choices are allowed) others □ (please specify)
Not involving the source of funds √
3. Shares of listed companies owned by investors and persons acting in concert before and after the change
Shares held before this change shares held after this change
Nature of shares in total share capital proportion in total share capital proportion number of shares (10000 shares) (%) number of shares (10000 shares) (%)
Total shares held 4584.64 5.00% 2751.64 3.0009%
Including: shares with unlimited sales conditions 4584.64 5.00% 2751.64 3.0009%
Shares with limited sales conditions 0
4. Implementation of commitments, plans, etc
Whether this change is performance yes □ no √
Commitment, intention and plan made. If yes, please explain the specific situation of commitment, intention and plan and the progress of implementation. Whether there is any violation of the securities law and the regulations of Listed Companies in this change
Purchase management measures and other laws, yes □ no √
Administrative regulations and departmental rules. If yes, please explain the specific situation of violations, rectification plan and treatment measures. Normative documents and business rules of the exchange 5 Shares with restricted voting rights
According to Article 60 of the securities law, yes □ no √
Whether the provisions of Article 3 exist. If so, please explain the proportion of the corresponding number of shares in the share capital of the existing listed company. Non voting shares 6 Further description of the transfer of voting rights (if applicable)
The entrusting party After the entrustment, the proportion of pre entrusted shares in the total share capital and the price date proportion (%) shall be calculated according to the identity of the same trustee's name / surname
Not applicable: principal □ trustee □
The restricted number of shares entrusted this time and the future 18
Months of share disposal arrangements or commitments are not applicable
Specify the main contents of the agreement or arrangement, including
Trustee, trustee's rights and obligations, term and inapplicability
Cancellation conditions, other special agreements, etc. 7. Further explanation on the increase of shares held by more than 30% shareholders (if applicable)
Whether the increase complies with the purchase of listed companies
The exemption from tender offer stipulated in the administrative measures shall not apply
situation
Not applicable within the legal period of shareholders and their persons acting in concert
Commitment not to reduce shares of the company 8 Documents for reference 1. Details of shareholding changes of China Securities Depository and Clearing Co., Ltd. □ 2. Relevant written commitment documents □ 3. Written opinions of lawyers □ 4. Other documents required by Shenzhen Stock Exchange √
It is hereby announced.
Hybio Pharmaceutical Co.Ltd(300199) board of directors January 25, 2022
